News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Entertainment

Sandra Bullock’s alleged stalker gets July trial date

sandrabullock

Joshua Corbett, 39, pleaded not guilty to charges including stalking and possession of a machine gun.

in Music

The science of popular music

beatles

A new study shows there have been three major movements in American music since 1964.

in Entertainment

Super son Ashton Kutcher remodels his mom’s house

ashton-kutcher2

The "That '70s Show" star is giving his mom a Mother's Day she'll never forget.